The pursuit of targeted metabolic interventions has driven significant interest in peptide research throughout 2026. While GLP-1 receptor agonists have dominated the landscape, researchers are increasingly investigating compounds that target fat metabolism directly without affecting appetite or insulin sensitivity. AOD-9604 has emerged as one of the most prominent peptides in this category, offering a unique […]
